Hims & Hers Health, Inc. - 8-K Filing

Hims & Hers Health reported Q1 2026 revenue of $608 million (up 4% YoY), with subscribers reaching nearly 2.6 million (+9% YoY). The company raised full-year 2026 guidance to $2.8 billion–$3.0 billion in revenue and updated Adjusted EBITDA guidance to $275 million–$350 million. (Items: 2.02 The information in this Current Report on Form 8-K and Exhibit 99)

SEC EDGAR ·

Tickers: $HIMS

Read the full article at SEC EDGAR

More Regulatory news